Loss-of-function mutations in cell cycle regulators CDKN2A and CDKN2B are more frequent in ATCs with respect to DTCs suggesting they play a key role in anaplastic transformation, making it a potential prognostic factor in DTCs. The gene discussed is CDKN2A; the disease is Ehlers-Danlos syndrome, musculocontractural type.